Atea Pharmaceuticals Inc (AVIR) — Financial Flexibility Index
Atea Pharmaceuticals Inc (AVIR) has a Financial Flexibility Index of -0.71x as of December 2025. Free cash flow of $-28.22 Million (operating CF $-28.22 Million minus capex $0.00) represents -1% of total liabilities ($39.78 Million). Also explore how fast is Atea Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Atea Pharmaceuticals Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Atea Pharmaceuticals Inc across 8 annual periods. Check Atea Pharmaceuticals Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Atea Pharmaceuticals Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Atea Pharmaceuticals Inc. For the full company profile including market capitalisation, see Atea Pharmaceuticals Inc market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.32x | $-132.03 Million | $-132.03 Million | $39.78 Million | ▲ +36.8% |
| 2024 | -5.25x | $-135.50 Million | $-135.50 Million | $25.80 Million | ▼ -144.6% |
| 2023 | -2.15x | $-85.39 Million | $-85.39 Million | $39.78 Million | ▲ +52.9% |
| 2022 | -4.55x | $-119.04 Million | $-120.98 Million | $26.14 Million | ▼ -228.8% |
| 2021 | -1.39x | $-87.00 Million | $-87.00 Million | $62.81 Million | ▼ -247.4% |
| 2020 | 0.94x | $296.76 Million | $296.73 Million | $315.83 Million | ▲ +625.4% |
| 2019 | -0.18x | $-12.81 Million | $-12.81 Million | $71.64 Million | ▼ -60.9% |
| 2018 | -0.11x | $-7.90 Million | $-7.91 Million | $71.02 Million | — |